Navigation Links
Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women
Date:10/28/2009

IRVINE, Calif., Oct. 28 /PRNewswire/ -- Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year. What's more, women age 25 and older now have a tool to help them understand their potential risk for breast cancer. Based on the same science as the PAP test for cervical cell changes, HALO® is the only FDA-cleared risk assessment tool for non-hereditary breast cancer. HALO can help identify women at increased risk for breast cancer years before a lump might appear, allowing for clinical intervention aimed at prevention and early detection.

It is estimated that 11,000 breast cancer diagnoses occur each year in women under the age of 40 who are too young for mammograms, and that 85% of women diagnosed with the condition have no direct family history of the disease. Yet all too often, women rely solely on mammograms and breast exams to detect abnormal tissue or believe they are not at risk if they do not have breast cancer in their family.

"Before HALO, it was very difficult to collect cells from the breast ducts that might help us identify women who are at risk for developing breast cancer, particularly women too young for mammography," said Alison L. Laidley MD, FACS, FRCS(C), of Breast Surgeons of North Texas. "HALO may help physicians identify women who need close monitoring or perhaps further testing because they are at increased risk."

Screening for abnormal cells (also called atypia) with HALO can help women and their doctors identify precancerous changes, closely monitor them and develop an optimal care path aimed at prevention. Women found to have atypia are four-to-five times more likely to develop breast cancer in the future.

HALO is designed as a complement to mammography and breast exams, the current standard screening for breast cancer. HALO is not a replacement for current routine screening with br
'/>"/>

SOURCE NeoMatrix, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
3. Do Women Have a Right to a Breastpump That Works? Asks Hygeia
4. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
5. Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
6. Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer
7. Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says
8. New stem cell identification technology could cure breast cancer
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
11. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ALEXANDRIA, Va. , July 2, 2015 /PRNewswire/ ... signed an agreement with ASHP, an organization that ... serve as a provider of continuing education for ... a designated track of geriatric programs for this ... Consultant Pharmacists as authorized providers for the CCGP ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/9q4d5d/veterinary_ ) has ... Vaccines Market by Product, Diseases & Technology - Global ... The global animal vaccines market is poised to ... 2015, at a CAGR of 5.5% from 2015 to ... growing prevalence of animal diseases, increasing incidences of zoonotic ...
(Date:7/2/2015)... , July 2, 2015 ... to improving access to HIV treatments   ... strategic manufacturing agreement to enable production in China ... source of the dolutegravir active pharmaceutical ingredient (API), and will ... finished product (dolutegravir 50mg, marketed under the name Tivicay®) for ...
Breaking Medicine Technology:Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... for the third quarter of 2009, which includes a ... primarily from strong cash collections related to prior period ... of $32.1 million for the comparable period in 2008, ...
... (Nasdaq: ROCM ) today announced operating results for its ... Company reported sales of $9,009,000 for the current quarter compared ... The Company reported a quarterly net loss of $229,000 or ... or $.03 per diluted share for the fourth quarter of ...
Cached Medicine Technology:Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 3Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 4Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 7Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 8Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 9Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 10Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 11Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 2Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 3Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 4Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 5Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 6Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 7Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 8Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 9Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 10Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 11Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 12
(Date:7/2/2015)... ... , ... The ZAC Foundation, a national leader in water safety education and ... to stay water safe with the help of a young polar bear named Zeke. ... co-founders, follows Zeke’s water safety journey. Zeke, who is afraid of the water ...
(Date:7/2/2015)... Mirada, CA (PRWEB) , ... July 02, 2015 ... ... addition of Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery ... dislocations, disc herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and ...
(Date:7/2/2015)... NY (PRWEB) , ... July 02, 2015 , ... ... for Carpal Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of ... – and a leading international authority on the conservative treatment of back, hip, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... education software, announced today a new release of their flagship product, 3D Tooth ... new Human Dentition quiz section and new tutorial videos. This latest release of ...
(Date:7/2/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions ... hired Robert Trenschel, DO, as chief executive officer. A veteran physician executive with 20 ... duties at Yuma Regional Medical Center on July 13. , “Dr. Trenschel brings an ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3
... ... has released a new mobile/cellular telephone aimed at the senior citizen marketplace. ... be both easy to see and easy to use. By offering safety ... contacts (up to 4) until it connects, and a high intensity LED ...
... ... American Association for Respiratory Care (AARC). PHS received the recognition under a new AARC ... access to respiratory care services provided by qualified respiratory therapists. , ... St. Paul, MN (Vocus) March 8, ...
... ... focus on tasks, but scientists now report that Ritalin also directly enhances the speed of learning. ... San Francisco, CA (Vocus) March ... to focus on tasks, but SCSF scientists now report that Ritalin also directly enhances the speed ...
... ... ... , ... , , , ...
... ... ... ... ...
... MO - Breast cancer patients with early stage disease that ... from radiation after mastectomy, because of the low present-day risk ... that could one day change the course of treatment for ... The University of Texas M. D. Anderson Cancer. The ...
Cached Medicine News:Health News:Easy to See and Use Senior Phone Works with AT&T and T-Mobile Cellular Providers 2Health News:Pediatric Home Service (PHS) Named Quality Respiratory Care Provider 2Health News:Pediatric Home Service (PHS) Named Quality Respiratory Care Provider 3Health News:Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research 2Health News:Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research 3Health News:Special Session Highlights Late-Breaking Abstracts 2Health News:Special Session Highlights Late-Breaking Abstracts 3Health News:Special Session Highlights Late-Breaking Abstracts 4Health News:Special Session Highlights Late-Breaking Abstracts 5Health News:Revisions to Health Care Reform Must Include Rate Freeze, Rate Regulation and States' Rights Provisions, Says Consumer Watchdog 2Health News:Revisions to Health Care Reform Must Include Rate Freeze, Rate Regulation and States' Rights Provisions, Says Consumer Watchdog 3Health News:Revisions to Health Care Reform Must Include Rate Freeze, Rate Regulation and States' Rights Provisions, Says Consumer Watchdog 4Health News:Revisions to Health Care Reform Must Include Rate Freeze, Rate Regulation and States' Rights Provisions, Says Consumer Watchdog 5Health News:Revisions to Health Care Reform Must Include Rate Freeze, Rate Regulation and States' Rights Provisions, Says Consumer Watchdog 6Health News:Most early stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early stage breast cancer patients may not need radiation after mastectomy 3
Inquire...
Inquire...
... Anatomical Malar I Implants - Providing ... implant follows the contour of the zygoma ... prominence. Anatomical Malar II Implants - ... the surgeon with another augumentation option that ...
... - Anatomically designed to enhance the chin contour, ... mandible with a high-profile central chin projection. ... entire mandible, this implant provides a high central ... arms. Cleft Chin Implants - Designed with ...
Medicine Products: